10 Oct 2018 --- A formulation containing AstaReal natural astaxanthin can provide a 40 percent increase in endurance and significantly improves muscle function in sarcopenia sufferers. This is according to a study by AstaMed investigating muscle loss and functional decline in older adults with the disease. Sarcopenia affects nearly a quarter of adults older than 60. Researchers published the findings in The Journal of Cachexia, Sarcopenia and Muscle on the effectiveness of a new medical protocol to improve muscular function.
28 Sep 2018 --- Keurig Dr Pepper (KDP) has entered into a definitive agreement to acquire enhanced beverage company Core Nutrition LLC at a value of US$525 million, or approximately US$435 million net of anticipated tax benefits. The acquisition represents KDP's latest move in the evolution of its allied brands portfolio.
24 Sep 2018 --- Sunar Misir plans to reach an installed capacity of 100,000 tons for its sorbitol and maltitol facility in Adana (Turkey) by the end of 2019. Sunar Mısır has over 33 years of experience with corn-based ingredients and offers sustainably-sourced, Non-GMO starches and starch derivatives for the global market.
10 Aug 2018 --- Salutivia has been appointed as the UK distributor for DSM Nutritional Products within the food, nutrition and supplement markets for customers served through the DSM distributor supply chain.
08 Aug 2018 --- The UK advertising watchdog has ruled that McDonald’s Happy Meals can be advertised during children’s TV shows because they are “healthy.” But it banned ads for KFC and Kellogg’s Coco Pops for promoting junk food to young people. The Advertising Standards Authority (ASA) dismissed a complaint that a Pokémon-themed Happy Meal ad, which featured products including Chicken McNuggets, should not have been allowed to run between episodes of Peppa Pig.
07 Aug 2018 --- DSM is pursuing a patent infringement lawsuit in China against a competitor for what it calls the “misappropriation of intellectual property” pertaining to the production of a key ingredient of Biotin (also known as Vitamin B7 or Vitamin H). On August 2, 2018, DSM IP Assets BV and two related operating group companies, DSM Vitamins (Shanghai) Ltd. and DSM Vitamins Trading (Shanghai) Ltd. served a suit against Anhui Tiger in China for patent infringement.
07 Aug 2018 --- PLT Health Solutions, Inc. has revealed the results of a clinical study the company helped develop has been published in the highly-regarded scientific journal, Diabetes, Obesity and Metabolism. Entitled “Efficacy of a novel herbal formulation for weight loss demonstrated in a 16‐week randomized, double‐blind, placebo‐controlled clinical trial with healthy overweight adults” (Dixit, et al. 2018), the publication describes clinical evaluation of Slendacor Weight Management Complex, which was introduced to the market in 2017.
06 Aug 2018 --- The European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) has recognized egg membrane hydrolysate BiovaFlex as novel food pursuant to Regulation (EU) 2015/2283. According to the applicant, Biova LLC (the supplier of BiovaFlex), the ingredient holds particular market potential due to its natural sourcing credentials as well as the convenience it brings by being water-soluble.
02 Aug 2018 --- Two new guides have been published in India to help the country’s health supplement industry adapt to recently implemented regulatory requirements. Produced by the Resource Centre for Health Supplements and Nutraceuticals (ReCHaN), their publication is significant because they aim to function as a key stepping stone towards ensuring consistency of practice across India’s supplement industry and will assist in the application of relevant legislation governing the sector.
01 Aug 2018 --- Specialty chemicals company DSM has reported a second-quarter core profit of €508 million (US$593.2 million), up 35 percent compared to Q2 2017, boosted by an “exceptional vitamin pricing environment” and cost cuts. The company has further confirmed its outlook for the full year, based on expectations of an Adjusted EBITDA growth towards 25 percent and a related higher ROCE growth.
25 Jul 2018 --- Lonza has updated its outlook for the full year after reporting 8.2 percent organic (like-for-like) sales growth, double-digit organic CORE EBITDA and CORE EBIT growth during the first half of 2018. The company attributes growth to the successful integration of Capsugel and “buoyant demand” from pharmaceutical and biotech clients for products including viruses for gene therapy.
04 Jul 2018 --- The demand for natural, sustainable and integrated solutions, as well as growing calls for expressing bioavailability are all key drivers for today’s health and nutrition products, Frutarom’s President of Natural Solutions, Yoni Glickman has said. The business unit, which offers Flavor & Color, Food Protection and Health Benefits, accounts for about 25 percent of Frutarom’s turnover. An integrated cognitive health platform will be just one of the target areas for growth for the business, in the run-up to Frutarom’s US$7.1 billion acquisition by International Flavors & Fragrances (IFF), which was announced last May.
04 Jul 2018 --- Dean Foods Company has increased its ownership percentage and taken a majority stake in Good Karma Foods, a US brand known for its flaxseed-based milk and yogurt alternatives. The investment points to Dean Foods' commitment to plant-based foods and beverages at a time when more and more consumers are looking to minimize their consumption of animal-derived products.
04 May 2018 --- Lonza has reported a “positive” start to 2018 led by the businesses along the healthcare continuum. The former Capsugel business, now part of Lonza Pharma & Biotech and Lonza Consumer Health, has shown a strong performance following good progress on business and functional integration, the company reports, without giving any details on financial figures. For the coming months, Lonza has announced plans to expand facilities in the US.
02 May 2018 --- Nexira, a global leader in natural and organic ingredients for the food, health and nutrition industries, has announced a strategic partnership agreement with Omega Pharma NV, one of the largest OTC healthcare companies in Europe and Inqpharm Group (a Zaluvida company), a specialty pharmaceutical company.
20 Apr 2018 --- Fermentalg, a French supplier of microalgae for nutrition and health, has reported first-quarter revenue of €232k whereas no income was recorded in Q1 2017. As of 31 March 2018, Fermentalg held gross cash and cash equivalents of €19.5 million compared to €21.8 million at 31 December 2017. Cash burn amounted to a €2.5 million outflow, stable compared to the previous quarter (excluding financing activities) and down €0.5 million from Q1 2017. Q1 was marked by progress achieved in bringing to market its DHA ORIGINS range of algal oils naturally rich in omega 3, as well as a US distribution agreement with Stauber, a leading North American supplier of specialty ingredients, the company reports.
13 Apr 2018 --- CJ CheilJedang is making plans to build a production line, dedicated to the creation of L-Arginine and L-Citrulline at its Jombang plant, in Indonesia, which will start operating in 2019. The company currently produces nucleic acid, MSG, arginine and histidine at the Jombang plant. Meanwhile, the company is also planning to improve the productivity of L-Citrulline at its outpost, Ningbo production plant in China.
12 Apr 2018 --- DSM has pre-announced better-than-expected earnings for the first quarter and raised its 2018 outlook on upbeat sales, with an additional boost from high prices in vitamins. The first quarter benefited from an additional Adjusted EBITDA contribution estimated at €165 million from an exceptional vitamin pricing environment. DSM raised its 2018 adjusted EBITDA forecast to "toward" 25 percent from earlier guidance for a rise of at least high single-digit growth.
27 Mar 2018 --- GlaxoSmithKline (GSK) has reached an agreement with Novartis for the acquisition of Novartis’ 36.5 percent stake in its Consumer Healthcare Joint Venture for US$13 billion, just days after GSK exited the race to buy Pfizer's Consumer Healthcare Business. GSK reports that the Consumer Healthcare Business is well positioned to drive sales and earnings growth, powered by “category-leading Power Brands, science-based innovation and improved efficiencies.” Novartis reports that the sale will enable it to further focus on the development and growth of its core businesses.
16 Mar 2018 --- A US$70 million investment in a new nutrition bar manufacturing plant in Ontario, California has been announced by Nellson Nutraceutical (Nellson), a North American formulator and manufacturer of branded and private label nutritional bars and functional powders.